GHK-Cu
From £22
- Home
- Regenerative
- ARA-290
In stock, ships today
- Purity: ≥99% (HPLC)
- Independent lab report for the batch you receive
- For laboratory research use only
£28
- Only 4 left in the UK warehouse
- Order within 12h 10m for dispatch today, estimated delivery Thu 12 Nov
- Free UK delivery over £100
- Discreet, plain unbranded packaging
Third-party lab report
Batch ARA10.222 99% purity Tested 8 Jun 2026
Pay by bank
About ARA-290
ARA-290 is a synthetic peptide derived from the B-helix region of erythropoietin (EPO), modified to selectively engage tissue-protective signalling pathways without activating classical erythropoietic activity. It is investigated in preclinical models as an agonist of the innate repair receptor (IRR) complex, a heteromer involving the erythropoietin receptor and the CD131 (beta common) subunit.
Primary areas of investigation
- Innate repair receptor signalling research
- JAK2/STAT pathway investigation
- PI3K/Akt cascade studies
- Inflammatory cytokine pathway research
- Mitochondrial stress response models
- Cell culture survival pathway studies
Mechanism
Research into ARA-290 examines its interaction with the tissue-protective receptor complex (IRR) and downstream JAK2/STAT and PI3K/Akt pathway activity in experimental systems. In preclinical models, it is investigated for its effects on inflammatory signalling cascades and cellular survival pathway research. Studies focus on innate repair mechanism investigation under controlled laboratory conditions.
Delivery and returns
Shipped in plain, unbranded packaging from our United Kingdom warehouse. Damaged on arrival? Tell us within 48 hours and we’ll put it right. Shipping and returns
For laboratory research use only. Not for human or veterinary use.
